UW23077
OPEN TO ACCRUAL
Correlating Early FDG PET/CT and ctDNA in ICI-Treated Melanoma Patients
UW25072
OPEN TO ACCRUAL
Phase 1b/2 Trial of Hepzato Kit & Opdualag for Metastatic Melanoma and Liver Metastasis
UW24061
OPEN TO ACCRUAL
Ph 3 Study w/Combo of Fianlimab+Cemiplimab vs Relatlimab+Nivo in Participants w/Metastatic Melanoma
UW24110
OPEN TO ACCRUAL
Ph2/3 Open-label RP2 w/ Nivolumab vs Ipilimumab w/ Nivolumab in pts w Mets Uveal Melanoma
UW25011
OPEN TO ACCRUAL
Phase 1 Study of PF-07799544 as Monotherapy or combo in Participants w/ BRAF-Mutant Melanoma
UW18132
OPEN TO ACCRUAL
Evaluation of Circulating Tumor Cells in Melanoma
UW21049
OPEN TO ACCRUAL
PII Hypofractionated VS conventional fractionated RT in soft tissue sarcomas